Aytu BioPharma, Inc. et al v. Granules Pharmaceuticals Inc.

1:24-cv-01356 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Colm F. Connolly
Filed Dec. 11, 2024
Case Flags ANDA and PATENT
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Cause 35:271 Patent Infringement
Jury Demand None
The docket is incomplete. Sign up for verified information.
Filing Date # Docket Text
3/17/2025Stipulation-General (See Motion List for Stipulation to Extend Time)
3/17/2025Proposed Order
3/13/2025SO ORDERED
3/12/2025Stipulation to EXTEND Time
3/3/2025Notice of Service
2/28/2025SO ORDERED
2/28/2025Stipulation to EXTEND Time
2/26/2025SO ORDERED, -District Court Pro Hac Vice Fee - 04 Attorneys Credit Card Payment
2/25/2025Appear Pro Hac Vice
2/3/2025Remark: The February 5, 2025 Telephonic Scheduling Conference is cancelled per the filing of the Proposed Scheduling Order with no areas of dispute at D.I. 15. (mws) (Entered: 02/03/2025)
1/30/2025NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Aytu BioPharma, Inc., Neos Therapeutics, Inc., Neos Therapeutics, LP.(Tigan, Jeremy) (Entered: 01/30/2025)
1/30/2025Joint PROPOSED ORDER -- [Proposed] Scheduling Order -- re 12 Order Setting Scheduling Conference, by Aytu BioPharma, Inc., Neos Therapeutics, Inc., Neos Therapeutics, LP. (Attachments: # 1 Cover Letter to The Honorable Colm F. Connolly)(Tigan, Jeremy) (Entered: 01/30/2025)
1/17/2025Supplemental Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aytu BioPharma, Inc. for Neos Therapeutics, Inc.; Corporate Parent Neos Therapeutics, Inc., Corporate Parent PharmaFab Texas, LLC for Neos Therapeutics, LP filed by Aytu BioPharma, Inc., Neos Therapeutics, Inc., Neos Therapeutics, LP. (Tigan, Jeremy) (Entered: 01/17/2025)
1/13/2025ORAL ORDER re 5 Disclosure Statement filed by Aytu BioPharma, Inc., Neos Therapeutics, LP, Neos Therapeutics, Inc. WHEREAS Plaintiff's 7.1 Disclosure Statement (D.I. 5) does not comply with Chief Judge Connolly's Standing Order Regarding Disclosure Statements, Plaintiff shall within 7 days of the date of this order submit a revised disclosure statement. Ordered by Judge Colm F. Connolly on 1/13/2025. (mws). (Entered: 01/13/2025)
1/13/2025NOTICE OF SERVICE of Defendant, Granules Pharmaceuticals Inc.'s Production of Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery filed by Granules Pharmaceuticals Inc..(Myer, R.) (Entered: 01/13/2025)
1/8/2025Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 2/5/2025 at 01:30 PM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 1/8/2025. (mws) (Entered: 01/08/2025)
1/7/2025 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Granules India Limited for Granules Pharmaceuticals Inc. filed by Granules Pharmaceuticals Inc.. (Myer, R.) (Entered: 01/07/2025)
1/7/2025 ANSWER to 1 Complaint by Granules Pharmaceuticals Inc..(Myer, R.) (Entered: 01/07/2025)
12/19/2024Pro Hac Vice Attorney Andrew J. Cochran, Colleen Tracy James, Heon Goo (Nick) Lee, Peter J. Armenio for Aytu BioPharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 12/19/2024)
12/19/2024SO ORDERED, re 6 MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Colleen Tracy James, Andrew J. Cochran, and Heon Goo (Nick) Lee. Ordered by Judge Colm F. Connolly on 12/19/2024. (mws) (Entered: 12/19/2024)
12/19/2024STANDING ORDER REGARDING BRIEFING IN ALL CASES. (mws) (Entered: 12/19/2024)
12/18/2024Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 12/18/2024)
12/17/2024WAIVER OF SERVICE returned executed by Neos Therapeutics, Inc., Aytu BioPharma, Inc., Neos Therapeutics, LP: For Granules Pharmaceuticals Inc. waiver sent on 12/12/2024, answer due 2/10/2025. (Tigan, Jeremy) (Entered: 12/17/2024)
12/12/20247Pro Hac Vice Fee - Credit Card Payment received for Peter J. Armenio, Colleen Tracy James, Andrew J. Cochran, and Heon Goo (Nick) Lee. ( re 6 MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Colleen Tracy James, Andrew J. Cochran, and Heon Goo (Nick) Lee )( Payment of $ 200, receipt number ADEDC-4568676).(Tigan, Jeremy) (Entered: 12/12/2024)
12/12/2024MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Colleen Tracy James, Andrew J. Cochran, and Heon Goo (Nick) Lee - filed by Aytu BioPharma, Inc., Neos Therapeutics, Inc., Neos Therapeutics, LP. (Tigan, Jeremy) (Entered: 12/12/2024)
12/11/2024No Summons Issued. (mpb) (Entered: 12/11/2024)
12/11/2024 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aytu BioPharma, Inc. for Neos Therapeutics, Inc., Neos Therapeutics, LP filed by Aytu BioPharma, Inc., Neos Therapeutics, Inc., Neos Therapeutics, LP. (mpb) (Entered: 12/11/2024)
12/11/2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,709,491 B2; 8,840,924 B2; 9,017,731 B2; 9,265,737 B2. (mpb) (Entered: 12/11/2024)
12/11/2024 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/1/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/1/2027. (mpb) (Entered: 12/11/2024)
12/11/2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 12/11/2024)
12/11/2024COMPLAINT against Granules Pharmaceuticals Inc. (Filing fee $ 405, receipt number ADEDC-4567278) - filed by Neos Therapeutics, Inc., Aytu BioPharma, Inc., Neos Therapeutics, LP. (Attachments: # 1 Exhibits A-D, # 2 Civil Cover Sheet)(mpb) (Entered: 12/11/2024)